The risk of developing cloudy lenses in the eyes may be linked to the use of cholesterol-lowering drugs known as statins, according to a new study.

While the researchers cannot prove the drugs caused the eye condition, they found that people who took statins – such as Zocor and Lipitor – were about 27 per cent more likely to develop cataracts, compared to people who did not take the medication.

“The results were consistent that there was a higher risk of being diagnosed with cataracts among statin users,” Ishak Mansi, the study’s senior author from UT Southwestern Medical Centre and the Dallas VA Medical Centre in Texas, said.

Statins are popular drugs that block a substance the body needs to make cholesterol, which can get trapped in arteries and ultimately lead to heart attacks and strokes.

The drugs are especially recommended for people with diabetes or a history of cardiovascular problems.

Researchers have looked at the link between statins and cataracts before with mixed results. While some studies found that taking statins lowered the risk of developing cataracts, other studies found the drugs increased the risk.

For the new research, Mansi and his colleagues used data collected from the medical records of people between the ages of 30 and 85 who were enrolled in one healthcare system in San Antonio, Texas, and received care between 2003 and 2005.

In one analysis, they compared about 7,000 people who were on statins for at least 90 days to about 7,000 people who were not on statins but were similar in about 40 other characteristics, including other health conditions, medications and healthcare use.

The drugs are especially recommended for people with diabetes or a history of cardiovascular problems

About 36 per cent of statin users were diagnosed with cataracts, compared to about 34 per cent of people not taking statins.

In a second analysis, the researchers looked at people with no other known health conditions. It included 6,113 statin users and 27,400 people who did not take statins.

After adjusting the results for the participants’ age, sex, weight, medications, healthcare use, other vision conditions and cigarette, alcohol and drug use, the researchers found about 34 per cent of statin users were diagnosed with cataracts, compared to about 10 per cent of people not taking statins.

What’s more, the researchers found that the risk of developing cataracts increased with the length of time a person took the medication.

While Mansi and his colleagues cannot say how statins may affect the formation of cataracts, they write in Jama Ophthalmology that there are a few possible explanations.

One is that the body needs high levels of cholesterol to maintain a clear lens and statins may interfere with the cells that control that process.

Jack Cioffi, head of ophthalmology at Columbia University Medical Center in New York, said the study is very well done but has some limitations, including that the researchers used billing data rather than medical records, so they can’t say how severe the cataracts were.

“I don’t think we should overstate the significance of this. It goes back to if there is a good reason for you to be on that statin, it outweighs the risk of a mild increase in risk of cataract,” Cioffi, who was not involved in the new study, said.

He added that the treatments for cataracts have evolved over time. The National Institutes of Health says the procedures to remove cataracts are some of the most common and safest surgeries performed in the US.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.